Interim Update of the MDR-101-MLK Phase 3 Trial: MERCURY Study: FR-OR43

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2020-10, Vol.31 (10S), p.28-28
Main Authors: Kaufman, Dixon, Stegall, Mark D., Marin, Ethan P., Gaber, Ahmed O., Srinivas, Titte, Stites, Erik, Busque, Stephan, Mai, Martin L., Cooper, Matthew, Crowley, Suzanne, Piper, James B., Shah, Asheh P., Akkina, Sanjeev, Chavin, Kenneth
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 28
container_issue 10S
container_start_page 28
container_title Journal of the American Society of Nephrology
container_volume 31
creator Kaufman, Dixon
Stegall, Mark D.
Marin, Ethan P.
Gaber, Ahmed O.
Srinivas, Titte
Stites, Erik
Busque, Stephan
Mai, Martin L.
Cooper, Matthew
Crowley, Suzanne
Piper, James B.
Shah, Asheh P.
Akkina, Sanjeev
Chavin, Kenneth
description
doi_str_mv 10.1681/ASN.20203110S128a
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1681_ASN_20203110S128a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1681_ASN_20203110S128a</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1681_ASN_20203110S128a3</originalsourceid><addsrcrecordid>eNqdzjsKwkAUheEpFHwuwO5uIPHeiSZiIUiMKBqRPAqrYdAJRqIJM7HI7lWwsbU61X_4GBsR2uTOaLyMDzZHjg4RxsRnssW6hBPXcl3P6bCeMTdEmnLP67LF9lErnd8hrS6yVlBmUF8VhKvIIiQr3O_geJVGgQOJzmUxhzCI_DQ6QVw_L82AtTNZGDX8bp_ROkj8jXXWpTFaZaJ6n0vdCELxwYk3TvzgnH-aF4vTQN8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Interim Update of the MDR-101-MLK Phase 3 Trial: MERCURY Study: FR-OR43</title><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Kaufman, Dixon ; Stegall, Mark D. ; Marin, Ethan P. ; Gaber, Ahmed O. ; Srinivas, Titte ; Stites, Erik ; Busque, Stephan ; Mai, Martin L. ; Cooper, Matthew ; Crowley, Suzanne ; Piper, James B. ; Shah, Asheh P. ; Akkina, Sanjeev ; Chavin, Kenneth</creator><creatorcontrib>Kaufman, Dixon ; Stegall, Mark D. ; Marin, Ethan P. ; Gaber, Ahmed O. ; Srinivas, Titte ; Stites, Erik ; Busque, Stephan ; Mai, Martin L. ; Cooper, Matthew ; Crowley, Suzanne ; Piper, James B. ; Shah, Asheh P. ; Akkina, Sanjeev ; Chavin, Kenneth ; Mercury Study Group</creatorcontrib><identifier>ISSN: 1046-6673</identifier><identifier>DOI: 10.1681/ASN.20203110S128a</identifier><language>eng</language><ispartof>Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.28-28</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Kaufman, Dixon</creatorcontrib><creatorcontrib>Stegall, Mark D.</creatorcontrib><creatorcontrib>Marin, Ethan P.</creatorcontrib><creatorcontrib>Gaber, Ahmed O.</creatorcontrib><creatorcontrib>Srinivas, Titte</creatorcontrib><creatorcontrib>Stites, Erik</creatorcontrib><creatorcontrib>Busque, Stephan</creatorcontrib><creatorcontrib>Mai, Martin L.</creatorcontrib><creatorcontrib>Cooper, Matthew</creatorcontrib><creatorcontrib>Crowley, Suzanne</creatorcontrib><creatorcontrib>Piper, James B.</creatorcontrib><creatorcontrib>Shah, Asheh P.</creatorcontrib><creatorcontrib>Akkina, Sanjeev</creatorcontrib><creatorcontrib>Chavin, Kenneth</creatorcontrib><creatorcontrib>Mercury Study Group</creatorcontrib><title>Interim Update of the MDR-101-MLK Phase 3 Trial: MERCURY Study: FR-OR43</title><title>Journal of the American Society of Nephrology</title><issn>1046-6673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqdzjsKwkAUheEpFHwuwO5uIPHeiSZiIUiMKBqRPAqrYdAJRqIJM7HI7lWwsbU61X_4GBsR2uTOaLyMDzZHjg4RxsRnssW6hBPXcl3P6bCeMTdEmnLP67LF9lErnd8hrS6yVlBmUF8VhKvIIiQr3O_geJVGgQOJzmUxhzCI_DQ6QVw_L82AtTNZGDX8bp_ROkj8jXXWpTFaZaJ6n0vdCELxwYk3TvzgnH-aF4vTQN8</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Kaufman, Dixon</creator><creator>Stegall, Mark D.</creator><creator>Marin, Ethan P.</creator><creator>Gaber, Ahmed O.</creator><creator>Srinivas, Titte</creator><creator>Stites, Erik</creator><creator>Busque, Stephan</creator><creator>Mai, Martin L.</creator><creator>Cooper, Matthew</creator><creator>Crowley, Suzanne</creator><creator>Piper, James B.</creator><creator>Shah, Asheh P.</creator><creator>Akkina, Sanjeev</creator><creator>Chavin, Kenneth</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202010</creationdate><title>Interim Update of the MDR-101-MLK Phase 3 Trial: MERCURY Study</title><author>Kaufman, Dixon ; Stegall, Mark D. ; Marin, Ethan P. ; Gaber, Ahmed O. ; Srinivas, Titte ; Stites, Erik ; Busque, Stephan ; Mai, Martin L. ; Cooper, Matthew ; Crowley, Suzanne ; Piper, James B. ; Shah, Asheh P. ; Akkina, Sanjeev ; Chavin, Kenneth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1681_ASN_20203110S128a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaufman, Dixon</creatorcontrib><creatorcontrib>Stegall, Mark D.</creatorcontrib><creatorcontrib>Marin, Ethan P.</creatorcontrib><creatorcontrib>Gaber, Ahmed O.</creatorcontrib><creatorcontrib>Srinivas, Titte</creatorcontrib><creatorcontrib>Stites, Erik</creatorcontrib><creatorcontrib>Busque, Stephan</creatorcontrib><creatorcontrib>Mai, Martin L.</creatorcontrib><creatorcontrib>Cooper, Matthew</creatorcontrib><creatorcontrib>Crowley, Suzanne</creatorcontrib><creatorcontrib>Piper, James B.</creatorcontrib><creatorcontrib>Shah, Asheh P.</creatorcontrib><creatorcontrib>Akkina, Sanjeev</creatorcontrib><creatorcontrib>Chavin, Kenneth</creatorcontrib><creatorcontrib>Mercury Study Group</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaufman, Dixon</au><au>Stegall, Mark D.</au><au>Marin, Ethan P.</au><au>Gaber, Ahmed O.</au><au>Srinivas, Titte</au><au>Stites, Erik</au><au>Busque, Stephan</au><au>Mai, Martin L.</au><au>Cooper, Matthew</au><au>Crowley, Suzanne</au><au>Piper, James B.</au><au>Shah, Asheh P.</au><au>Akkina, Sanjeev</au><au>Chavin, Kenneth</au><aucorp>Mercury Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interim Update of the MDR-101-MLK Phase 3 Trial: MERCURY Study: FR-OR43</atitle><jtitle>Journal of the American Society of Nephrology</jtitle><date>2020-10</date><risdate>2020</risdate><volume>31</volume><issue>10S</issue><spage>28</spage><epage>28</epage><pages>28-28</pages><issn>1046-6673</issn><doi>10.1681/ASN.20203110S128a</doi></addata></record>
fulltext fulltext
identifier ISSN: 1046-6673
ispartof Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.28-28
issn 1046-6673
language eng
recordid cdi_crossref_primary_10_1681_ASN_20203110S128a
source PubMed Central; EZB Electronic Journals Library
title Interim Update of the MDR-101-MLK Phase 3 Trial: MERCURY Study: FR-OR43
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T11%3A03%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interim%20Update%20of%20the%20MDR-101-MLK%20Phase%203%20Trial:%20MERCURY%20Study:%20FR-OR43&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Kaufman,%20Dixon&rft.aucorp=Mercury%20Study%20Group&rft.date=2020-10&rft.volume=31&rft.issue=10S&rft.spage=28&rft.epage=28&rft.pages=28-28&rft.issn=1046-6673&rft_id=info:doi/10.1681/ASN.20203110S128a&rft_dat=%3Ccrossref%3E10_1681_ASN_20203110S128a%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-crossref_primary_10_1681_ASN_20203110S128a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true